LOXL2 inhibition ameliorates pulmonary artery remodeling in pulmonary hypertension
J. Steppan, H. Wang, K. Nandakumar, A. Poe, L. Pak, T. Brady, M. Gadkari, D. E. Berkowitz, L. A. Shimoda, L. Santhanam
This study shows LOXL2 inhibition reduces pulmonary artery stiffness and improves survival in pulmonary hypertension models.
bioRxiv · Oct 24, 2023Physiology